Corticotropin-releasing hormone, corticotropin-releasing hormone-binding protein, and activin A in maternal serum: Prediction of preterm delivery and response to glucocorticoids in women with symptoms of preterm labor

American Journal of Obstetrics and Gynecology

Volumn 183, Issue 3, 2000, Pages 643-648

  Coleman, Matthew A G ^a   France, John T ^a   Schellenberg, Jean Claude ^a   Ananiev, Valentin ^a   Townend, Kevin ^a   Keelan, Jeffrey A ^a   Groome, Nigel P ^b   McCowan, Lesley M E ^a  

^a UNIVERSITY OF AUCKLAND   (New Zealand)

^b OXFORD BROOKES UNIVERSITY   (United Kingdom)

Author keywords

Activin A; Antenatal glucocorticoids; Corticotropin releasing hormone; Corticotropin releasing hormone binding hormone; Preterm delivery; Preterm labor

Indexed keywords

ACTIVIN A; CORTICOTROPIN RELEASING FACTOR; CORTICOTROPIN RELEASING FACTOR RECEPTOR; DEXAMETHASONE SODIUM PHOSPHATE; ESTRIOL; GLUCOCORTICOID; HORMONE BINDING PROTEIN;

ARTICLE; BIRTH WEIGHT; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DELIVERY; DRUG EFFECT; ESTRIOL BLOOD LEVEL; FEMALE; FETUS LUNG MATURATION; GESTATIONAL AGE; HORMONE BLOOD LEVEL; HORMONE DETERMINATION; HOSPITAL ADMISSION; HUMAN; MAJOR CLINICAL STUDY; PREDICTION; PREMATURE LABOR; PREMATURITY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; STEROID THERAPY; VALIDATION PROCESS;

EID: 0033834373     PISSN: 00029378     EISSN: None     Source Type: Journal    
DOI: 10.1067/mob.2000.106592     Document Type: Article

References (28)

1. Corticotrophin-releasing hormone production by the placenta and fetal membranes
2. Oxytocin and its receptor in pregnancy and parturition: Current concepts and clinical implications
3. The molecular mechanisms of term and preterm labor: Recent progress and clinical implications
4. Placental corticotrophin-releasing hormone: There by accident or design?
5. A placental dock controlling the length of human pregnancy
6. Corticotropin-releasing factor and its binding protein: Maternal serum levels in term and preterm deliveries
7. Inhibin and activin in human fetal membranes: Evidence for a local effect on prostaglandin release
8. Activin A, corticotropin-releasing factor and prostaglandin F2 alpha increase immunoreactive oxytocin release from cultured human placental cells
9. Changes in peripheral serum levels of total activin-A during the human menstrual cycle and pregnancy
10. Abnormal concentration of maternal serum activin-A in gestational diseases
11. Corticotropin releasing hormone-binding protein (CRH-BP): Plasma levels decrease during the third trimester of normal human pregnancy
12. Development and application of a two-site enzyme immunoassay for the determination of 'total' activin-A concentrations in serum and follicular fluid
13. Effect of betamethasone in vivo on placental corticotropin-releasing hormone in human pregnancy
14. Plasma corticotropin-releasing hormone concentrations during pregnancy and parturition
15. The diagnosis of preterm labor and the prediction of preterm delivery
16. Maternal corticotropin-releasing hormone is increased with impending preterm birth
17. Fetal fibronectin detection in preterm labor: Evaluation of a prototype bedside dipstick technique and cervical assessment
18. Episodic secretion of activin-A in pregnant women
19. Placental corticotrophin releasing factor may modulate human parturition
20. Corticotropin-releasing hormone increases prostaglandin F(2α) activity on human myometrium in vitro
21. The biological activity of the corticotropin-releasing hormone receptor-adenylate cyclase complex in human myometrium is reduced at the end of pregnancy
22. Corticotropin-releasing hormone-induced vasodilatation in the human fetal placental circulation
23. The human myometrial CRH receptor: G proteins and second messengers
24. Activin at parturition: Changes of maternal serum levels and evidence for binding sites in placenta and fetal membranes
25. Regulation of activin-A production by human amnion, decidua and placenta in vitro by pro-inflammatory cytokines
26. A controlled trial of antepartum corticosteroid treatment for prevention of the respiratory distress syndrome in premature infants
27. Effects of betamethasone on maternal plasma corticotropin releasing factor, ACTH and cortisol during pregnancy
28. Antenatal glucocorticoid administration increases corticotrophin-releasing hormone in maternal plasma